2022
DOI: 10.1111/exd.14642
|View full text |Cite
|
Sign up to set email alerts
|

Impaired calcium signalling and neuropsychiatric disorders in Darier disease: An exploratory review

Abstract: Darier (Darier‐White) disease (DD) is an autosomal dominant skin disorder caused by pathogenic mutations in the ATP2A2 gene which encodes a calcium ATPase in the sarco‐endoplasmic reticulum (SERCA2). Defects in the SERCA2 protein lead to an impairment of cellular calcium homeostasis, which in turn, triggers cell death pathways. There is a high prevalence of neuropsychiatric disorders in patients affected by this condition, namely intellectual disability, bipolar disorder, schizophrenia, and suicidality. Though… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 62 publications
(129 reference statements)
0
2
0
Order By: Relevance
“…At present, thapsigargin, a SERCA inhibitor, has become a commonly used drug to induce ERS and activate the UPR [ 19 , 20 ]. More importantly, the dysregulation of Ca 2+ homeostasis induced by SERCA is implicated in numerous pathological processes characterized by cognitive impairment as the primary clinical manifestation, including Darier’s disease, Alzheimer’s disorder, and cerebral ischemia [ 21 23 ]. It is believed that targeting SERCA to restore Ca 2+ homeostasis and alleviate neural apoptosis caused by ERS holds promise as a potential therapeutic strategy for neurodegenerative diseases.…”
Section: Introductionmentioning
confidence: 99%
“…At present, thapsigargin, a SERCA inhibitor, has become a commonly used drug to induce ERS and activate the UPR [ 19 , 20 ]. More importantly, the dysregulation of Ca 2+ homeostasis induced by SERCA is implicated in numerous pathological processes characterized by cognitive impairment as the primary clinical manifestation, including Darier’s disease, Alzheimer’s disorder, and cerebral ischemia [ 21 23 ]. It is believed that targeting SERCA to restore Ca 2+ homeostasis and alleviate neural apoptosis caused by ERS holds promise as a potential therapeutic strategy for neurodegenerative diseases.…”
Section: Introductionmentioning
confidence: 99%
“…At present, thapsigargin, a SERCA inhibitor, has become a commonly used drug to induce ERS and activate the UPR (Bian et al, 1997;Mengesdorf et al, 2001). More importantly, the dysregulation of Ca 2+ homeostasis induced by SERCA is implicated in numerous pathological processes characterized by cognitive impairment as the primary clinical manifestation, including Darier's disease, Alzheimer's disorder, and cerebral ischemia (Ambur et al, 2022;Britzolaki et al, 2020;Chemaly et al, 2018). It is believed that targeting SERCA to restore Ca 2+ homeostasis and alleviate neural apoptosis caused by ERS holds promise as a potential therapeutic strategy for neurodegenerative diseases.…”
Section: Introductionmentioning
confidence: 99%